Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Insider Insights

World’s first CRISPR medicine approved in UK for…

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick…
Read more
Articles

World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

News
18.06.2024
HTAi Annual Meeting 2024

We summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova…

Read more
Articles
18.06.2024
What does it take to secure access to digital heal…

Article originally published 11th August 2022, updated 18th June 2024. Introduction Digital health a…

Read more
Insider Insights
17.06.2024
Health Technology Assessment: HTACG provide update…

We discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea…

Read more
Insider Insights
12.06.2024
Scotland leads the UK in approving Mounjaro for ob…

Scottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils…

Read more
Articles
11.06.2024
AI could transform diabetes management to improve …

Article originally published 17th August 2022, updated 11th June 2024. Introduction Artificial intel…

Read more
Articles
05.06.2024
The impact of AI on drug pricing and reimbursement

Artificial intelligence is set to revolutionise the market access and healthcare landscape, but huma…

Read more
Insider Insights
30.05.2024
NICE and NHS England unveil plan to facilitate qui…

NHS and NICE propose faster adoption of MedTech, streamlining funding and market access for innovati…

Read more
Articles
29.05.2024
EU HTA regulation

Learn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol…

Read more
Articles
21.05.2024
How are local markets adapting their HTA evaluatio…

Our experts analyse how local European markets are integrating the EU HTA outputs into national proc…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.